158 related articles for article (PubMed ID: 17172465)
1. Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA cross-linking assays.
Johnson AA; Marchand C; Patil SS; Costi R; Di Santo R; Burke TR; Pommier Y
Mol Pharmacol; 2007 Mar; 71(3):893-901. PubMed ID: 17172465
[TBL] [Abstract][Full Text] [Related]
2. In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.
Savarino A
Retrovirology; 2007 Mar; 4():21. PubMed ID: 17374162
[TBL] [Abstract][Full Text] [Related]
3. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site.
Johnson AA; Sayer JM; Yagi H; Patil SS; Debart F; Maier MA; Corey DR; Vasseur JJ; Burke TR; Marquez VE; Jerina DM; Pommier Y
J Biol Chem; 2006 Oct; 281(43):32428-38. PubMed ID: 16943199
[TBL] [Abstract][Full Text] [Related]
4. Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking.
Adesokan AA; Roberts VA; Lee KW; Lins RD; Briggs JM
J Med Chem; 2004 Feb; 47(4):821-8. PubMed ID: 14761184
[TBL] [Abstract][Full Text] [Related]
5. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
6. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
[TBL] [Abstract][Full Text] [Related]
7. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
[TBL] [Abstract][Full Text] [Related]
8. Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis.
Xue W; Jin X; Ning L; Wang M; Liu H; Yao X
J Chem Inf Model; 2013 Jan; 53(1):210-22. PubMed ID: 23231029
[TBL] [Abstract][Full Text] [Related]
9. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
[TBL] [Abstract][Full Text] [Related]
10. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
Heuer TS; Brown PO
Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
[TBL] [Abstract][Full Text] [Related]
11. Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.
Métifiot M; Johnson BC; Kiselev E; Marler L; Zhao XZ; Burke TR; Marchand C; Hughes SH; Pommier Y
Nucleic Acids Res; 2016 Aug; 44(14):6896-906. PubMed ID: 27369381
[TBL] [Abstract][Full Text] [Related]
12. New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action.
Ferro S; De Luca L; Barreca ML; De Grazia S; Christ F; Debyser Z; Chimirri A
Bioorg Med Chem; 2010 Aug; 18(15):5510-8. PubMed ID: 20630765
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA.
Liao C; Karki RG; Marchand C; Pommier Y; Nicklaus MC
Bioorg Med Chem Lett; 2007 Oct; 17(19):5361-5. PubMed ID: 17719223
[TBL] [Abstract][Full Text] [Related]
14. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
15. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
[TBL] [Abstract][Full Text] [Related]
16. Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides.
Brodin P; Pinskaya M; Buckle M; Parsch U; Romanova E; Engels J; Gottikh M; Mouscadet JF
Biochemistry; 2002 Feb; 41(5):1529-38. PubMed ID: 11814346
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase.
Espeseth AS; Felock P; Wolfe A; Witmer M; Grobler J; Anthony N; Egbertson M; Melamed JY; Young S; Hamill T; Cole JL; Hazuda DJ
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11244-9. PubMed ID: 11016953
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of HIV-1 integrase.
Chiu TK; Davies DR
Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551
[TBL] [Abstract][Full Text] [Related]
19. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants for HIV-1 integrase inhibition by beta-diketo acids.
Marchand C; Zhang X; Pais GC; Cowansage K; Neamati N; Burke TR; Pommier Y
J Biol Chem; 2002 Apr; 277(15):12596-603. PubMed ID: 11805103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
